PTHS
AMEX · Biotechnology

Pelthos Therapeutics Inc

Biotech Stocks Healthcare Stocks
$22.99
-0.33 (-1.42%)
As of Feb 8, 2:15 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +18.7% upside
Low Target $18.57
Average Target $27.28
High Target $35.01
Current Price $22.99
Current
$22.99
Target
$27.28
$18.57 $27.28 avg $35.01
Scenario Analysis
Bear Case
$18.57
-19.2%
Low target
Base Case
$27.28
+18.7%
Avg target
Bull Case
$35.01
+52.3%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$30.67
-25.0% from high
52-Week Low
$12.38
+85.7% from low
Target vs 52W High
$27.28
-11.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%